Imirestat

CAS No. 89391-50-4

Imirestat( AL 1576 | Alcon 1576 | HOE 843 )

Catalog No. M26715 CAS No. 89391-50-4

Imirestat is an aldose reductase inhibitor that can be used in diabetes research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 295 Get Quote
10MG 507 Get Quote
25MG 801 Get Quote
50MG 1107 Get Quote
100MG 1503 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Imirestat
  • Note
    Research use only, not for human use.
  • Brief Description
    Imirestat is an aldose reductase inhibitor that can be used in diabetes research.
  • Description
    Imirestat is an aldose reductase inhibitor that can be used in diabetes research.(In Vivo):Administration of 1 mg/kg Imirestat increased nerve conduction velocity, however, had no effect on resistance to hypoxic conduction block or deficits in insulin-stimulated Uban-sensitive ATPase activity.
  • In Vitro
    ——
  • In Vivo
    Imirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in insulin-stimulated oubain-sensitive ATPase activity.
  • Synonyms
    AL 1576 | Alcon 1576 | HOE 843
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    SIRT1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89391-50-4
  • Formula Weight
    286.238
  • Molecular Formula
    C15H8F2N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (291.13 mM)
  • SMILES
    Fc1ccc2-c3ccc(F)cc3C3(NC(=O)NC3=O)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Napper AD, et al. Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. J Med Chem. 2005 Dec 15;48(25):8045-54.
molnova catalog
related products
  • AT-007

    AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM).

  • Izonsteride

    Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.

  • Lidorestat

    Lidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts.